The pioneering purpose-built life science facility opens in March 2026

Glasgow, February, 2026

Located within the Glasgow Riverside Innovation District (GRID), the highly anticipated Health Innovation Hub (HiH) has secured Panthera as a new tenant ahead of its official opening next month. The announcement further strengthens the Hub’s growing community of healthcare innovators and highlights its role in supporting collaboration, growth and clinical excellence.

Panthera, which recruits patients and runs clinical trials for pharmaceutical and biotech companies and the seven largest Contract Research Organisations (CROs), is currently based within the Clinical Innovation Zone (CIZ) at Queen Elizabeth University Hospital. The move to the Health Innovation Hub will allow Panthera to expand its operations, increase capacity and offer even more opportunities for people in Glasgow to take part in clinical research.

This follows the news of digital chemistry company Chemify joining the roster of HiH alongside the Digital Health Validation Lab (DHVL). DHVL provides essential infrastructure and expertise to support innovators in building the evidence needed to guide decisions at critical points, including investment, regulatory approval, and market access.

HiH is Glasgow’s new purpose-built life science facility focused on advancing precision medicine technologies through the R&D stage ahead of commercialisation. This flagship investment is being delivered and operated by Kadans Science Partner, in collaboration with The Living Laboratory for Precision Medicine, a University of Glasgow-led programme that is at the forefront of translating cutting-edge science and innovation into real-world clinical settings.

Further cementing Glasgow as a leader in the science sector, the 87,000ft² of state-of-the-art flexible laboratory and office space of HiH will be home to some of the most exciting university spinouts, Scottish scale ups and established businesses within healthcare innovation. 

Mark Hanna, Director of Asset Management for Kadans Science Partner, said: “This is a historic moment for Glasgow and indeed the life science ecosystem in Scotland as the Health Innovation Hub will be a catalyst for healthcare innovation. Its location breathes new life into the area and being on the doorstep of the Queen Elizabeth University Hospital and the University of Glasgow’s Clinical Innovation Zone, offers unparalleled access to world-leading academics and outstanding clinical infrastructure and resources.

Dr Ruth McLaughlin, Programme Director for the Living Laboratory programme, said: “Set to become a cornerstone of Scotland’s healthcare innovation ecosystem, Health Innovation Hub will play a vital role in pioneering new solutions to some of today’s most pressing healthcare challenges, offering a collaborative environment where innovative ideas can move seamlessly from R&D through to commercialisation.

“It’s fantastic to see the first tenants being announced, including Chemify and Panthera, as HiH begins to build a vibrant community of innovators and collaborators who are looking to make a lasting impact on healthcare.”

Stuart Young, CEO at Panthera, commented, “We are delighted to be moving into this new centre of excellence as we expand our state of the art clinic to meet growing demand from our Sponsors and patients. This move will enable us to increase the number of people from Glasgow taking part in clinical trials, giving them access to cutting-edge treatments for life-changing conditions, years before they become widely available through the NHS.”

-----------------------------------------------------------------------------

Notes to Editor

Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors. We focus on bringing people together to overcome global challenges. Therefore, we invest, develop and operate specialised assets to complement science clusters. Across Europe, we have built a network of clients, partner organisations, and innovative minds, active in Life Sciences & Health, Agri & Food, Energy & Chemistry, and High Tech Systems & Materials. All determined to find solutions to the global challenges we face today. Currently already active in 30+ science clusters, our network continues to grow as we develop more locations and support more clusters across Europe.

For more information visit www.kadans.com.

About Panthera:

Panthera is the UK’s largest independent Site Management Organisation (SMO), specialising in patient recruitment and the delivery of clinical trials through a network of dedicated research clinics across the UK and Europe. Today, Panthera works with ten of the world’s top twelve pharmaceutical companies, many biotechs and the top-seven global CROs.

Recognised for speed, quality and reliability, Panthera helps sponsors accelerate study timelines and streamline the path to patients. In 2025, Panthera secured an investment from the leading private equity firm LDC to support continued growth and enhance clinical capabilities.

About the Living Laboratory:

The Living Laboratory for Precision Medicine is a University of Glasgow-led programme that accelerates the development, evaluation, and adoption of innovative healthcare solutions into real-world clinical settings. Rooted in collaboration, it brings together researchers, clinicians, and industry partners in a ‘triple helix’ partnership, harnessing their collective expertise to drive innovation into frontline healthcare. Through this concerted effort, the programme aims to improve patient outcomes, deliver significant cost savings for the NHS, and stimulate economic growth in Govan, Glasgow, and beyond.

About the University of Glasgow:

Founded in 1451, The University of Glasgow is a world-class university, committed to working with global partners to create high-quality research with real-life impact.

We were named the Scottish University of the Year by the Times & Sunday Times Good University Guide 2024 and have been home to world-changing research and teaching for more than 570 years.

Our research excellence responds to some of the world’s greatest challenges in areas such as precision medicine and chronic diseases, one health, future life, addressing inequalities, cultural and creative economies, and the nano and quantum world.

www.gla.ac.uk